Boston Scientific Corp (BSX)
73.26
+0.35
(+0.48%)
USD |
NYSE |
Apr 25, 16:00
75.16
+1.90
(+2.59%)
Pre-Market: 06:09
Boston Scientific Free Cash Flow: 1.703B for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
December 31, 2023 | 1.703B |
September 30, 2023 | 1.615B |
June 30, 2023 | 1.422B |
March 31, 2023 | 1.172B |
December 31, 2022 | 914.00M |
September 30, 2022 | 524.00M |
June 30, 2022 | 583.00M |
March 31, 2022 | 918.00M |
December 31, 2021 | 1.316B |
September 30, 2021 | 1.602B |
June 30, 2021 | 1.737B |
March 31, 2021 | 1.374B |
December 31, 2020 | 986.00M |
September 30, 2020 | 1.131B |
June 30, 2020 | 997.00M |
March 31, 2020 | 937.00M |
December 31, 2019 | 1.375B |
September 30, 2019 | 621.00M |
June 30, 2019 | 651.00M |
March 31, 2019 | 51.00M |
December 31, 2018 | -178.00M |
September 30, 2018 | 496.00M |
June 30, 2018 | 457.00M |
March 31, 2018 | 1.153B |
December 31, 2017 | 976.00M |
Date | Value |
---|---|
September 30, 2017 | 790.00M |
June 30, 2017 | 338.00M |
March 31, 2017 | 471.00M |
December 31, 2016 | 674.00M |
September 30, 2016 | 368.00M |
June 30, 2016 | 808.00M |
March 31, 2016 | 479.00M |
December 31, 2015 | 178.00M |
September 30, 2015 | 443.00M |
June 30, 2015 | 395.00M |
March 31, 2015 | 611.00M |
December 31, 2014 | 984.00M |
September 30, 2014 | 808.00M |
June 30, 2014 | 706.00M |
March 31, 2014 | 822.00M |
December 31, 2013 | 821.00M |
September 30, 2013 | 984.00M |
June 30, 2013 | 1.005B |
March 31, 2013 | 1.013B |
December 31, 2012 | 1.032B |
September 30, 2012 | 964.00M |
June 30, 2012 | 1.052B |
March 31, 2012 | 1.005B |
December 31, 2011 | 693.00M |
September 30, 2011 | 818.00M |
Free Cash Flow Range, Past 5 Years
524.00M
Minimum
Sep 2022
1.737B
Maximum
Jun 2021
1.136B
Average
1.131B
Median
Sep 2020
Free Cash Flow Benchmarks
Stryker Corp | 3.136B |
Abbott Laboratories | 5.059B |
Edwards Lifesciences Corp | 629.50M |
Intuitive Surgical Inc | 595.80M |
Axonics Inc | -5.566M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | 957.00M |
Cash from Investing (Quarterly) | -1.053B |
Cash from Financing (Quarterly) | 15.00M |
Free Cash Flow Per Share (Quarterly) | 0.4673 |
Free Cash Flow to Equity (Quarterly) | 488.00M |
Free Cash Flow to Firm (Quarterly) | 732.91M |
Free Cash Flow Yield | 1.59% |